Loxapine succinate is the succinate salt form of loxapine, a tricyclic dibenzoxazepine antipsychotic agent used as an active pharmaceutical ingredient. It acts by blocking dopamine receptors at postsynaptic sites in the limbic system, cortical system, and basal ganglia, reducing hallucinations and delusions associated with schizophrenia.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Loxapine succinate?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Loxapine
pharmaceutical raw material
Amoxapine
pharmaceutical raw material
Nicergoline
pharmaceutical raw material
Chloramphenicol
pharmaceutical raw material
Imidocarb
pharmaceutical raw material
Levobunolol hydrochloride
pharmaceutical raw material
The international HS code for Loxapine succinate (CAS 27833-64-3) is 2934.99.
2934.99
2934 99 90
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
butanedioic acid;8-chloro-6-(4-methylpiperazin-1-yl)benzo[b][1,4]benzoxazepine
YQZBAXDVDZTKEQ-UHFFFAOYSA-N
CN1CCN(CC1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl.C(CC(=O)O)C(=O)O
Sourcing Loxapine succinate?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.